Rodwige Desnoyers

Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study

The Lancet Oncology · 2019 · 234 citations

DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides

Cancer Chemotherapy and Pharmacology · 1997 · 55 citations